www.veristat.com Open in urlscan Pro
2606:2c40::c73c:67fe  Public Scan

Form analysis
0 forms found in the DOM

Text Content

We use cookies to improve your user experience, remember your preferences
support website function and analyse website traffic. For this reason, we may
share your site usage date with our analytics partners. By clicking “Accept,”
you consent to store on your device all technologies described in our Cookie
Policy.

Select Your Cookie Preferences
Accept All Cookies Decline
 * Careers
 * Events
 * Library
 * Global Reach
 * News


Toggle navigation
 * Why Veristat
   
   
   * About Us
   * Our Approach
   * Our Leadership
   * Success Stories
   * News
   * Locations
   * Careers
     
     
     * Open Positions
     * Core Values
     * Explore Benefits
     * Grow Your Career
     * Because We Care
     * Why Veristat
 * Therapeutic Areas
   
   
   * Oncology
   * Infectious Disease
   * Endocrine/Metabolic
   * CNS/Neurology
   * Cardiovascular Disease
   * Coronavirus
   * More Therapy Areas
 * Solutions
   
   
   * Cell and Gene Therapies
   * Virtual Trials
   * Rare Diseases
   * Rescue Trials
   * Vaccine Trials
   * Full Service
     
     
     * Clinical Trial Planning
     * Clinical Trial Conduct
     * Regulatory Submission
 * Services
   
   
   * Full Service
     
     
     * Clinical Trial Planning
     * Clinical Trial Conduct
     * Regulatory Submission
   * Strategic Consulting
     
     
     * Adaptive Designs
   * Regulatory Affairs
     
     
     * Regulatory Consulting
     * Marketing Applications
     * Agency Meetings
     * Regulatory Publishing
     * Medical Devices/IVDs
   * Clinical Operations
     
     
     * Project Management
     * Monitoring & Site Management
     * Patient Recruitment
     * Patient Retention & Site Engagement
   * Medical Affairs
     
     
     * Clinical Trial Safety
     * Data Review Committees
     * Medical Monitoring
   * Medical Writing
   * Biometrics
     
     
     * Data Management
     * Biostatistics
     * Statistical Programming
     * Standards Implementation
   * Pharmacovigilance
 * Knowledge Base
   
   
   * Library
   * Blog
   * Webinars
   * Success Stories
   * Newsletter
 * Contact Us
 * RFP


A FOCUS ON GETTING NOVEL THERAPIES TO PATIENTS EVERYWHERE

Proven global expertise in rare/ultra-rare disease therapeutic development, with
bold scientific strategies and a team unafraid of the big thinking required to
get your novel therapy to patients everywhere – quickly, safely, and
cost-effectively.


LEARN MORE

760+ Rare Disease Clinical Trials
140+ Marketing Applications Supported
12% of 2021 FDA Approvals
ODD Rare Disease Challenges



READ ARTICLE

Veristat Acquires DDR



READ PRESS RELEASE

Advancing Revolutionary Therapies Podcast



LISTEN NOW

SPECIALTY EXPERTISE

OUR TEAM OF SCIENTIFIC EXPERTS IS EASY TO WORK WITH, EVEN FOR THE RAREST, MOST
COMPLEX, AND NEVER DONE BEFORE NOVEL THERAPIES.

Cell & Gene Therapies
Covid-19
Oncology



Regulatory Affairs
Virtual Trials
All Services


DRIVING SUCCESS

   
Previous
Let me express my gratitude to the Veristat team for publishing our MAA…67 days
from database lock to filing! This is quite an accomplishment. It has truly been
a privilege to work with Veristat on this important milestone for our patients.
Director, Regulatory Operations
Clinical Stage Biopharmaceutical
I am grateful for the dedication, excitement and clinical trial expertise that
the Veristat team provided for our program. Veristat's collaboration was
critical to the successful clinical trials that led to our product's approval.
President of Research of Development
Mid-Size Pharma
Counting on Veristat for the preparation of our New Drug Application (NDA) is
the culmination of years of hard work and dedication by the Veristat team. I
have truly come to rely on the clinical and statistical expertise of Veristat
over the past decade.
Chief Executive Officer
Mid-Size Pharma
I wanted to let you know the protocol has been fully approved and is now
considered final. We could not have done this without you, and we are grateful
for your significant contributions.
Head of Regulatory & Medical Writing
Small Pharma
Thank you Veristat for your close collaboration and attentiveness during our
virtual inspection with the Japan PMDA. They have no further questions at this
point about our jNDA.
Sr Director of Statistical Programming
Mid-Size Biopharmaceutical
Let me express my gratitude to the Veristat team for publishing our MAA…67 days
from database lock to filing! This is quite an accomplishment. It has truly been
a privilege to work with Veristat on this important milestone for our patients.
Director, Regulatory Operations
Clinical Stage Biopharmaceutical
I am grateful for the dedication, excitement and clinical trial expertise that
the Veristat team provided for our program. Veristat's collaboration was
critical to the successful clinical trials that led to our product's approval.
President of Research of Development
Mid-Size Pharma
Counting on Veristat for the preparation of our New Drug Application (NDA) is
the culmination of years of hard work and dedication by the Veristat team. I
have truly come to rely on the clinical and statistical expertise of Veristat
over the past decade.
Chief Executive Officer
Mid-Size Pharma
I wanted to let you know the protocol has been fully approved and is now
considered final. We could not have done this without you, and we are grateful
for your significant contributions.
Head of Regulatory & Medical Writing
Small Pharma
Thank you Veristat for your close collaboration and attentiveness during our
virtual inspection with the Japan PMDA. They have no further questions at this
point about our jNDA.
Sr Director of Statistical Programming
Mid-Size Biopharmaceutical
Let me express my gratitude to the Veristat team for publishing our MAA…67 days
from database lock to filing! This is quite an accomplishment. It has truly been
a privilege to work with Veristat on this important milestone for our patients.
Director, Regulatory Operations
Clinical Stage Biopharmaceutical
Next
World-Class Teams Build on their Success with Veristat
SEE CUSTOMER SUCCESS STORIES


ULTRA-RARE DISEASE NH TRIALCASE STUDY


EUROPE GENE THERAPY TRIALCASE STUDY


TACKLING PROBLEMS BIG OR SMALL ? WE CAN HELP




WHAT ARE YOUR CHALLENGES?

WE CAN HELP

Lindsey Lukis
EVP Talent and Culture

 

It's no secret that the nature of our work can be demanding at times. That's
because the stakes are high. Our employees are intelligent, passionate,
dedicated people who understand their work truly makes a difference. They are
helping to extend and save lives, and that purpose binds us all. 

 

EXPLORE CAREERS

 * Why Veristat
   * About Us
   * Our Approach
   * Our Leadership
   * Success Stories
   * News
   * Locations
   * Careers
 * Therapeutic Areas
   * Oncology
   * Infectious Disease
   * Endocrine/Metabolic
   * CNS/Neurology
   * Cardiovascular Disease
   * Coronavirus
   * More Therapy Areas
 * Solutions
   * Cell and Gene Therapies
   * Virtual Trials
   * Rare Diseases
   * Rescue Trials
   * Vaccine Trials
   * Full Service
 * Services
   * Full Service
   * Strategic Consulting
   * Regulatory Affairs
   * Clinical Operations
   * Medical Affairs
   * Medical Writing
   * Biometrics
   * Pharmacovigilance
 * Knowledge Base
   * Library
   * Blog
   * Webinars
   * Success Stories
   * Newsletter
 * Careers
   * Open Positions
   * Core Values
   * Explore Benefits
   * Grow Your Career
   * Because We Care
   * Why Veristat

 * Privacy Policy
 * ©2006 - 2022 Veristat, LLC. All rights reserved. Veristat is a trademark of
   Veristat, LLC. All other trademarks are the property of their respective
   owners.


 * 
 * 
 *